Following its analysis of public offers 2021 on the French market, Ledouble presents an overview of these in a few key figures.
Assignments
Published on 21.09.2026
EUROBIO SCIENTIFIC
Ledouble acting as independent expert in the context of the public buyout offer followed by a squeeze-out to be launched by EB Development on Eurobio Scientific shares